Los científicos de la Facultad de Medicina de la Universidad de Pittsburgh (USA) aseguran que su vacuna contra el SARS-CoV-2, administrada a través de un parche minúsculo, genera anticuerpos específicos para el SARS-CoV-2 en cantidades que se consideran suficientes para neutralizar el virus. El artículo de EBioMedicine es el primer estudio revisado por pares publicado que describe una vacuna candidata para Covid-19. Es más que probable que en los próximos días vayan surgiendo nuevos estudios que nos sitúen cada vez más cerca de hallar la vacuna definitiva contra el coronavirus.
Fuentes: The Lancet, ABC
4 Comentarios
Would you like to fish in the virtual world? Play tiny fishing right now. Exciting and yet peaceful action for everyone.
ResponderEliminarInteresting article and a great read. The discussion about the vaccine research and its potential impact is really informative. I also enjoy discovering well-designed products, especially AP Moissanite watches and the detailed craftsmanship found in a moissanite watch.
ResponderEliminarIt is encouraging to see that the experimental vaccine produced enough antibodies to neutralize the virus in early tests. For a relaxing mental challenge afterward, I recommend trying 2048 6x6.
ResponderEliminarThis is fantastic news for the global health community! The progress in vaccine development, especially with the promising results against COVID-19, offers a glimmer of hope. It reminds me that even in challenging times, dedicated research can lead to breakthroughs. We're all looking forward to more updates, perhaps as eagerly as some anticipate the next level in Run 3
ResponderEliminar